Abiraterone acetate + prednisone for Prostate Cancer
Study Summary
This trial will study how well standard prostate cancer treatments work in different ethnic groups.
- Prostate Cancer
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What are the usual indications for this therapy?
"This medical intervention is not only useful for treating thyroiditis, but can also be effective in combating ulcerative colitis, malignant neoplasms, and varicella-zoster virus acute retinal necrosis."
Are there any open positions for volunteers in this clinical trial?
"That is correct. The clinicaltrials.gov website indicates that this trial, which was initially posted on May 23th 2019 and edited most recently on October 7th 2020, is currently recruiting patients. They are aiming to enroll 130 people from 3 different locations."
How many people can enroll in this research project?
"Yes, the information on clinicaltrials.gov indicates that this trial is recruiting patients. The trial was initially posted on 5/23/2019 and was most recently edited on 10/7/2022. The study is looking for 130 participants at 3 locations."
Is this a common treatment that has been well-researched?
"There are 378 total trials currently running that investigate this treatment, with 101 of those being in Phase 3. Duarte, California has the most studies for this treatment (n=?), but there are 17174 locations worldwide where these studies are taking place."
Has this intervention received the FDA's green light?
"While Phase 2 trials don't have any data supporting efficacy, this treatment still received a score of 2 for safety."